Related Experiment Video
Updated: Aug 30, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
Yoshikuni Mizuno1, Nobuo Yanagisawa, Sadako Kuno
1Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan. y_Mizuno@med.juntendo.ac.jp
Abstract:
We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Alterations in Muscle Tone lll
Parkinson Disease l: Introduction
Blinding
Blind Procedures